Clinical Trial Update: Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adjuvant sequential and concurrent Carboplatin-Taxol with radiotherapy for high-risk endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Carboplatin- Taxol (carboplatin; paclitaxel)
• Radiotherapy

Snippet

Sponsor: Loyola University | Conditions: Endometrial Cancer | Phase 2 | Status: UNKNOWN